Jump to content

Market News

  • entries
    1,036
  • comments
    265
  • views
    143,350

Contributors to this blog

About this blog

Entries in this blog

Pfizer Off Lows As It Sees $33.5 Billion Revenue From COVID Shots

Pfizer (NYSE:PFE) stock came off earlier lows in premarket trading Wednesday and was down 0.4% as the company raised its annual guidance and pegged revenue from sale of its COVID-19 vaccines at approximately $33.5 billion. The revenue from COVID-19 vaccines reflects 2.1 billion doses expected to be delivered in 2021 under already-signed contracts as of middle of this month. It could supply up to 3 billion doses if expansion at current sites happens and new suppliers are added, Pfizer said.
×
×
  • Create New...